New appearance for the global brand VivaScope.
May 2023 – VivaScope is proud to announce its new modern brand appearance. This refreshed look is a reflection of our commitment to innovation, technology, and customer service.
Take a closer look:
Our new brand appearance combines modern design elements and innovative technology to create a seamless and user-friendly experience for all of our customers. The sleek and sophisticated design of our new brand identity reflects our commitment to staying at the forefront of the ever-changing technology landscape. “We are excited to unveil our new modern brand appearance,” says Giuseppe Solomita, Director Sales & Marketing.
New emblem
Focusing on white color. For flexible use in multiple platforms.
We invite you to experience our new modern brand appearance and to discover the innovative technology that we have to offer.
New print layout.
With the two color scheme.
This refresh is a testament to our dedication to innovation and excellence in all aspects of our business.
Website.
Modern & intuitiv.
The new brand appearance will be launched across all of our platforms, including our website, social media, and marketing materials. We are confident that our new look will help us to continue to excel in the global technology industry.
Attachements
Contact Person:
News
Fluorescence Confocal Microscopy on Liver Specimens for Full Digitization of Transplant Pathology
September 2023 – Rapid evaluation of donor liver specimens for transplantation using the VivaScope® 2500 Technology
News
Double the number of patients at half the cost: digital innovation in Mohs surgery
The worldwide increase in cancer, predicted by the International Agency for Research on Cancer (IARC), requires the urgent optimisation and digitalisation of current treatment processes. A pioneering study led by Prof. Dr Jan Gutermuth at the University Hospital of Brussels presents a revolutionary approach: the integration of Ex Vivo Confocal Microscopy (EVCM) during Mohs Micrographic Surgery (MMS) for Basal Cell Carcinoma (BCC) using the VivaScope 2500, which has been proven to enable a more precise and faster assessment of tumour extension and resection margins, leading to a significant increase in efficiency. Prof Dr Jan Gutermuth and his team have proven that the waiting time for patients has been reduced, costs have been more than halved and the quality of patient care has been improved. The results have far-reaching implications for the healthcare system by enabling more effective and cost-efficient treatment of skin cancer.
News
Doppelte Patientenanzahl bei halben Kosten: Digitale Innovation in der Mohs-Chirurgie
Die weltweite Zunahme von Krebserkrankungen, prognostiziert durch die Internationale Agentur für Krebsforschung (IARC), erfordert die dringende Optimierung und Digitalisierung der gängigen Behandlungsprozesse. Eine wegweisende Studie unter der Leitung von Prof. Dr. Jan Gutermuth am Universitätsklinikum Brüssel präsentiert einen revolutionären Ansatz: die Integration von Ex Vivo Konfokaler Mikroskopie (EVCM) während der mikrographischen Chirurgie nach Mohs (engl. MMS) für das Basalzellkarzinom (BCC) mithilfe des VivaScope 2500. Damit ist nachweislich eine präzisere sowie schnellere Bewertung der Tumorausdehnung und Resektionsränder möglich, was zu einer erheblichen Effizienzsteigerung führt. Prof. Dr. Jan Gutermuth und sein Team haben bewiesen, dass die Wartezeit für Patienten verkürzt, die Kosten mehr als halbiert und die Qualität der Patientenversorgung gutverbessert wurden. Die Ergebnisse haben weitreichende Implikationen für das Gesundheitssystem, indem sie eine effektivere und kosteneffizientere Behandlung von Hautkrebs ermöglichen.